The Medical Letter on Drugs and Therapeutics
Sitagliptin/Metformin (Janumet) for Type 2 Diabetes
June 4, 2007 (Issue: 1262)Sitagliptin (Januvia) and metformin (Glucophage, and others) are now available in a single tablet (Janumet - Merck) for treatment of type 2 diabetes. The combination is approved by the FDA for use in patients not adequately controlled by sitagliptin...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.